Outcomes of emergency surgical treatment in malignant bowel obstructions.
OBJECTIVE
Malignant bowel obstructions are still a challenging problem for surgeons and carry high morbidity and mortality risk. The aim of this study was to review the presentation and outcomes of malignant bowel obstructions and to identify the risk factors related with poor prognosis.


METHODS
One hundred and twenty-five patients underwent emergency surgical treatment for malignant obstructions between January 1997 and January 2002. Data included age, sex, past medical history, presenting symptoms; physical findings on admission, American Society of Anesthesiologists (ASA) class, operative details, postoperative complications, length of hospitalization and hospital mortality were reviewed retrospectively.


RESULTS
Seventy-three (58%) of the patients have poor performance status on admission. Potentially curative resection was performed in 74 (60%) patients. Surgical treatment was palliative in 43 (34%) patients. Extended bowel resections were utilized in 20 (16%) patients. Our hospital mortality rate was 21%, and postoperative morbidity rate was 31%. Coexisting cardiopulmonary diseases, presence of generalized perforation, poor general condition and extended bowel resections appeared to be related with unfavorable outcomes.


CONCLUSIONS
Emergency surgical treatment for malignant obstruction may be curative in selected patients with good performance status.
Kulah
Bahadir
B
3rd Surgical Department, Ankara Numune Teaching and Research Hospital, Ankara, Turkey. bakulah@medscape.com
Ozmen
M Mahir
MM
Ozer
M Vasfi
MV
Oruç
M Tahir
MT
Coskun
Faruk
F
D000008:Abdominal Neoplasms / Q000150:complications; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004067:Digestive System Neoplasms / Q000150:complications; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013160:Splenic Neoplasms / Q000150:complications; D016896:Treatment Outcome; D014565:Urogenital Neoplasms / Q000150:complications